Skip to content

Implementation Science strategic platform - Seed grant round 1  

Director of the Implementation Science component of Maridulu Budyari Gumal, Sydney Partnership for Health, Education, Research and Enterprise (SPHERE) Platform, Professor Sandy Middleton commented on the high level of interest in the scheme. ‘This was the first time the Implementation Science Platform was able to offer seed grants and we received applications from a wide range of clinical specialities and disciplines’ said Professor Middleton. Over thirty applications were received, demonstrating the clear demand for implementation science research funding within SPHERE. The projects funded covered a range of clinical specialities including vascular disease, palliative care, heart failure and paediatrics. Successful applications represented six Clinical Academic Groups (CAG) - Respiratory, Sleep, Environmental, and Occupational Health; Palliative Care; Age and Ageing; Cardiac and Vascular Health; Cancer; and Early Life Determinants of Health. Two of the successful five projects included more than one CAG. Successful applicants also included two SPHERE academic partners - the University of Technology, Sydney and University of New South Wales, and included multidisciplinary nursing, medical and allied health teams. The grants aim to develop translational research knowledge and, in the future, encourage project teams to apply for larger grants including the Commonwealth’s Medical Research Future Fund and the New South Wales Translational Research Grants Scheme. The Implementation Science Platform looks forward to following the outcomes of these projects and their impact on the patient care following their completion by August 2022.

The successful applications for 2020 are:

Using behaviour change theory to drive scalability of the hand-held fan for chronic breathlessness.

Dr Tim Luckett

Faculty of Health, UTS

CAG: Respiratory, Sleep, Environmental, and Occupational Health; Palliative Care; Age and Ageing; Cancer

Implementation of Walking Tall against Vascular Disease for at-risk patients in a vascular clinical practice.    

Dr Matthew Brodie

Biomedical Engineering, UNSW

CAG: Cardiac and Vascular Health

Improve knowledge of fatigue management in life-limiting illness: an implementation science m-Health project.        

Dr Kat Urban

Head of Department, Palliative Medicine Staff Specialist

Prince of Wales Hospital, Randwick NSW

CAG: Palliative Care

Healthier Wealthier Families: A pilot feasibility trial addressing child poverty through health care service delivery.                

Dr Jade Burley

Research Associate 

Faculty of Medicine, UNSW

CAG: Early Life Determinants of Health

The HF-PC Implementation project: meeting patient and/or carer needs in Heart Failure-Palliative-Care.      

A/Professor Louise Hickman

Director of Palliative Care Studies

IMPACCT study, UTS   

CAG: Cardiac and Vascular Health; Age and Ageing; Palliative Care

First 2000 Days Care Connect - Grant Success for ELDoH CAG

Congratulations to Maridulu Budyari Gumal Early Life Determinants of Health Clinical Academic Group ((ELDoH CAG) members Ms Tania Rimes and Associate Professor Sue Woolfenden (Chief Investigators) who were awarded $840,547 through the Translational Research Grants Scheme by the New South Wales Health for their project entitled 'First 2000 Days Care Connect'.

Early/mid-career cancer researchers awarded Cancer Clinical Academic Group seed grants

Maridulu Budyari Gumal (SPHERE) Cancer Clinical Academic Group has committed $100,000 in new seed grants for two interdisciplinary projects led by early/mid-career researchers (EMCRs) to be undertaken in 2021.

Congratulations to the successful awardees and their teams.

New liquid biopsies could provide hope for brain cancer patients

Increasing the efficacy of brain cancer treatment traditionally requires access to tissue samples that can shed light on a tumour’s genetic makeup. But, with many malignancies buried deep inside essential areas of the brain, this tissue is often impossible to reach.

A new research project led by Associate Professor Therese Becker of the Ingham Institute is aiming to solve this problem. Using ‘liquid biopsies’ – that is, blood tests – the researchers hope to reveal critical information about individual patient tumours.